Interclean Shanghai

Insight Imaging signs definitive agreement to acquire eight imaging centers

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

EU Begins Revision of Medical Device...

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical...

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI...

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

InSight Health Services Holdings Corp. ("Insight Imaging") announced that it had signed a definitive agreement to acquire eight imaging centers in the Phoenix, Arizona, El Paso, Texas, and Las Cruces, New Mexico areas from subsidiaries of MedQuest, Inc. and Novant Health, Inc., for a total purchase price of approximately $8.5 million. The centers generated approximately $18.7 million in net revenues in 2009. In a separate transaction, Insight Imaging has agreed to sell mobile imaging assets in North Carolina for approximately $9.2 million to an affiliate of MedQuest and Novant. The mobile imaging assets generated approximately $3.3 million in net revenues in 2009. Insight Imaging expects the transactions, which are expected to close in July 2010, to be accretive to adjusted EBITDA after reflecting anticipated operating synergies.

Kip Hallman, President and CEO of Insight Imaging said, "We are excited to be able to add these strategically well-placed imaging centers to our existing markets. We believe that their addition will improve our strategic positioning and value to our referring physicians, patients and payers."

Latest stories

Related stories

EU Begins Revision of Medical Device Regulatory Framework

The European Commission has gone on to initiate a...

FDA Seeks Opinion on AI-Enabled Medical Devices Regulation

The U.S. Food and Drug Administration (US FDA) is...

FDA Approves Zenix Monitor-Defibrillator from ZOLL

ZOLL®, which happens to be an Asahi Kasei company...

MHRA in the UK Accelerates AI Rollout in the NHS

The Medicines and Healthcare Products Regulatory Agency (MHRA) from...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Translate »